Clinical trial
A Prospective Interventional Pilot Study on the Use of Valproic Acid for Treatment of Idiopathic Nephrotic Syndrome
NCT02896270 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Interventional Pilot Study on the Use of Valproic Acid for Treatment of Idiopathic Nephrotic Syndrome
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- October 31, 2016
- Completion date
- December 31, 2019
- Enrollment
- 15 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
focal segmental glomerulosclerosis, idiopathic nephrotic syndrome, minimal change disease